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Lymphoid/Neuronal Cell Surface OX2 Glycoprotein
Recognizes a Novel Receptor on Macrophages
Implicated in the Control of Their Function
IgSF glycoproteins including NCAM, Thy-1, and L1,
which are all expressed on both lymphoid and neuronal
tissue but are not generally expressed on other cell
types (Clark et al., 1985; McCaughan et al., 1987; Barclay
et al., 1997). N-CAM and L1 are involved in mediating
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Both the broad pattern of distribution and short cyto-
plasmic region that is devoid of any known signaling
motifs make the deduction of its function difficult. How-Summary
ever, like many other leukocyte surface proteins, OX2
contains two IgSF domains and thus seems likely toThe OX2 membrane glycoprotein (CD200) is expressed
interact with another cell surface protein (Barclay eton a broad range of tissues including lymphoid cells,
al., 1997). The IgSF domains are organized in a similar
neurons, and endothelium. We report the character- manner to the structurally related costimulatory mole-
ization of an OX2 receptor (OX2R) that is a novel pro- cules B7-1 and B7-2 that are also genetically closely
tein restricted to cells of the myeloid lineage. OX2 linked to OX2 (Borriello et al., 1998). Indeed, both stimu-
and its receptor are both cell surface glycoproteins latory (Borriello et al., 1997) and tolerogenic (Gorczynski
containing two immunoglobulin-like domains and in- et al., 1998, 1999a, 1999b, 1999c) roles for OX2 in antigen
teract with a dissociation constant of 2.5 mM and koff presentation have been proposed. A key question in
0.8 s21, typical of many leukocyte protein membrane understanding the function of OX2 is the identification
and characterization of its specific binding partner orinteractions. Pervanandate treatment of macrophages
receptor (OX2R).showed that OX2R could be phosphorylated on tyro-
We have previously reported the identification of asine residues. Blockade of the OX2±OX2R interaction
receptor for OX2 expressed on the surface of resi-with an OX2R mAb exacerbated the disease model
dent macrophages obtained from the peritoneal cavityexperimental allergic encephalomyelitis. These data,
(RPCs) of both rats and mice (Preston et al., 1997). Thetogether with data from an OX2-deficient mouse (R. M.
interaction was demonstrated using a soluble recombi-Hoek et al., submitted), suggest that myeloid function
nant form of OX2 presented as a highly multimeric array
can be controlled in a tissue-specific manner by the immobilized on fluorescent beads (Brown et al., 1995,
OX2±OX2R interaction. 1998; Preston et al., 1997). This generates a highly avid
binding reagent that addresses the technical problems
Introduction encountered when detecting leukocyte cell surface pro-
tein±protein interactions that are typified by extremely
Immunoglobulin superfamily (IgSF) domains are the low affinities due to very fast off rate kinetics (van der
most common domain type present at the surface of Merwe and Barclay, 1994, 1996). We now report the
leukocytes, and, of around 250 leukocyte cell surface molecular identification and biochemical properties of
proteins that have been sequenced, about one-third the OX2R, a kinetic analysis of its interaction with OX2
contain IgSF domains, and nearly half of these contain and functional analysis in a disease model. These data
just two IgSF domains (Barclay et al., 1997). The IgSF provide a molecular basis for the recent finding that
fold seems to be particularly suited to mediate recogni- OX2-deficient mice (R. M. Hoek et al., submitted) have
tion events either with other cell surface proteins such defects in their myeloid compartment and together
as CD2 with CD58 (Barclay et al., 1997; Davis et al., strongly suggest a role for the OX2±OX2R interaction in
the tissue-specific control of myeloid cellular biology.1998) or with soluble factors such as Fc receptors with
immunoglobulins (Heijnen and van de Winkel, 1997). The
OX2 protein (CD200) belongs to a group of leukocyte Results
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In a previous study, a receptor for OX2 was identifiedk Present address: Imperial Cancer Research Fund, 61 Lincoln's Inn
Fields, London WC2A 3PX, United Kingdom. on both rat and mouse resident peritoneal cells (RPCs).
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Figure 1. Generation of mAb OX102 and Bio-
chemical Analysis of the OX2R
(A) Staining of rat RPCs with mAbs OX102
(bold) and an isotype-matched negative con-
trol (OX21).
(B) Rat RPCs were preincubated with OX45
(anti-rat CD48) or OX102 mAbs and tested
for their ability to bind rOX2CD4d314-coated
beads. rOX2 binding was blocked back to
a negative control (CD4d314-coated beads,
thin line) by OX102 (bold line) but not by the
control OX45 (dotted line).
(C) The rOX2R was purified from deoxycho-
late solubilized crude rat spleen Tween-40
membrane preparations by immunoprecipi-
tation and further resolved under nonreduc-
ing (NR) and reducing (R) conditions by SDS-
PAGE.
(D) Purified rOX2R was left untreated (U) or
was incubated with PNGaseF for the indi-
cated times, then resolved under nonreduc-
ing conditions by SDS-PAGE, blotted onto
nitrocellulose, and probed with OX102 mAb.
This interaction was demonstrated by using a recombi- mass of the glycoprotein was contributed by N-linked
carbohydrate. The N-terminal amino acid sequence ofnant soluble form of the extracellular part of rat OX2
engineered as a chimeric protein containing two IgSF the purified protein was: SCPDK-QTMQ-NSSTMTEVV.
The blank cycles (2), were assumed to be asparaginedomains of rat CD4(d314) and immobilizing this protein
(rOX2CD4d314) via a biotinylated anti-rat CD4 mAb due to the predicted presence of N-linked glycans. A
third asparagine conforming to a potential glycosylation(OX68) to biotinylated fluorescent beads coated in strep-
tavidin (Preston et al., 1997). A monoclonal antibody site was not modified, probably due to its proximity to
a glycosylated site. This protein was identified as novel(mAb), OX88, that recognized mouse macrophages and
blocked the interaction was raised (Preston et al., 1997), by screening databases of known proteins with this se-
quence.but all attempts to biochemically characterize the recep-
tor using this IgM mAb were unsuccessful. In this study,
further mAbs were raised against rat macrophages, and Cloning and Sequencing of OX2R Show
one mAb, OX102 (IgG1), bound the majority of rat RPCs It Is a Novel Member of the IgSF
(Figure 1A) and blocked the binding of OX2-coated The amino terminal protein sequence was used to de-
beads back to a negative control (Figure 1B) and pre- sign an antisense degenerate primer to amplify the 59
sumably recognized the rat OX2 receptor (rOX2R). untranslated region and leader sequence of the rat OX2R
using a RT-PCR 59 RACE procedure, and the full-length
cDNA was subsequently obtained using a 39 RACE RT-The OX102 Antigen, rOX2R, Is a Novel Macrophage
Membrane Glycoprotein PCR protocol. A closely related protein (mOX2R) was
also identified in mouse using cross-species PCR andThe antigen recognized by mAb OX102 (rOX2R) was
purified by immunoprecipitation from rat splenic lysates. a full-length cDNA obtained by nested 39 RACE PCR
(see Experimental Procedures for details).Unusually, the antibody±antigen interaction was not dis-
rupted by conventional treatments of high pH, and elu- Structurally, OX2R resembles OX2, itself containing 2
IgSF domains in a typical V/C2 set arrangement, a singletion was achieved by treating the immunocomplexes
with 0.5% SDS at 558C. SDS-PAGE analysis revealed transmembrane region, but has a larger cytoplasmic
domain than OX2. The cDNA translations (Figure 2A)rOX2R as a broad 60±100 kDa band (Figure 1C) that
correlated well with Western blots of whole rat RPC contain several unusual features including additional se-
quence before the predicted A strand at the start of the Vlysates (data not shown). N-linked carbohydrate moi-
eties were enzymatically removed from purified rOX2R domain, four conserved extracellular cysteine residues
distinct from the canonical B to F strand IgSF disul-by PNGaseF treatment, which reduced the size of the
rOX2R (as visualized by Western blot) to three bands of phides in the V set domain, and two in the C2 set domain.
There are eight and ten potential N-linked glycosylationaround 25 kDa (Figure 1D), indicating that z70% of the
Macrophage OX2 Receptor
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Figure 2. OX2 and Its Receptor Are Related Members of the Immunoglobulin Superfamily
(A) An alignment of the rat and mouse OX2R amino acid sequences. The two sequences have been split according to predicted domain
organization. The superscripted bars in the extracellular regions predict the extent of the b sheets characteristic of the immunoglobulin fold
by comparison to solved structures. The nucleotide sequences corresponding to these proteins have been deposited in the GenBank database
under accession numbers AF231392 (rat) and AF231393 (mouse).
(B) Phylogenetic analysis of OX2 and its receptor. The two N-terminal IgSF domains of rat (r) and mouse (m) OX2R, OX2, CD80, CD86, NCAM,
CD2, and CD48 were aligned using ClustalW (Thompson et al., 1994) and then manually refined before constructing a neighbor-joining tree
with 1000 bootstrap trials.
sites in the rat and mouse, respectively, consistent with may lead to intracellular signals affecting macrophage
function.the very high level of glycosylation noted at the biochem-
A phylogenetic analysis (Figure 2B) of the OX2R extra-ical level (see above). Based on other IgSF interactions
cellular sequence with respect to other members of the(Davis et al., 1998), the GFC face of the V domain is
IgSF reveals that the OX2R is closely related to OX2likely to be the site of OX2 binding and correspondingly
itself, implying the two proteins have evolved from ais predicted to be free of N-linked carbohydrate.
common ancestral protein.The 67 amino acid cytoplasmic domain contains three
conserved tyrosine residues, one of which is contained
within a NPXY motif. NPXY motifs are known to bind The OX102 Antigen Is the Receptor for OX2
PTB/PID domains that are present in signaling adaptor The effective blocking of OX2 bead binding to macro-
molecules such as SHC, IRS-1, and Numb (Forman-Kay phages by the OX102 mAb is a good indicator that the
OX102 antigen is the OX2R. To formally prove this, theand Pawson, 1999), suggesting that engagement by OX2
Immunity
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Figure 3. The OX2R Binds OX2
(A) HEK 293T cells were transfected with rat
OX2R cDNA and stained for OX102 mAb (bold
line), the endogenous human MHC class I
with mAb W6/32 (dotted line), and a negative
control mAb (OX21, thin line). Mock trans-
fected cells stained with OX102 mAb showed
no staining greater than the negative control
(data not shown).
(B) rOX2R cDNA transfected 293T cells prein-
cubated with OX102 (bold), but not W6/32
(dotted), were able to block binding of rOX2-
coated beads back to a negative control (thin
line). Mock transfected cells did not bind
rOX2-coated beads (data not shown).
(C) Staining of rat thymocytes with mAbs OX1
(dotted line), OX2 (bold line), and an isotype-
matched negative control OX21.
(D) Rat thymocytes preincubated with mAb
OX2 (bold), but not OX1 (dotted), were able to
block the binding of rat OX2R-coated beads
back to the negative control (thin line).
The negative controls in (B) and (D) are
CD4d314-coated beads.
full-length rOX2R cDNA was expressed in a human kid- binding is represented by the difference in response
units (RU) observed in the rOX2R and control flow cellney endothelium cell line. Transfected cells could be
stained with the OX102 mAb (Figure 3A) and could also (Figure 4A) once equilibrium has been reached and is
plotted as a binding curve (Figure 4B). A KD of 2.5 mMbind OX2-coated beads (Figure 3B). The binding of OX2-
coated beads could be prevented by preincubating the was obtained by nonlinear curve fitting to this binding
curve, which agrees well with a KD of about 2 mM ob-cells with OX102 but not an irrelevant antibody (W6/
32) (Figure 3B), showing conclusively that the OX102 tained from a linear fit to a Scatchard plot of the same
data (Figure 4B, inset).antigen is the rOX2R.
The interaction was demonstrated in the reverse ori- Kinetic analysis of the interaction at 378C yielded a
koff of 0.8 s21 for both high and low levels of OX2R immo-entation by producing a recombinant, soluble form of
the rOX2R with a C-terminal peptide to allow specific bilization, indicating that kinetic measurements were not
grossly affected by rebinding or mass transport effectsbiotinylation of the protein using the BirA enzyme and
attachment to avidin-coated beads (Brown et al., 1998). (Figure 4C). kon values were calculated by fitting the
association binding phase to a simple 1:1 binding modelRat thymocytes, a major site of OX2 protein expression
(Figure 3C), bound rOX2R-coated beads, and this bind- using a koff of 0.8 s21 and were about 4 3 105 M21s21.
These values are comparable to those measured foring could be blocked by prior incubation of the cells
with the OX2 mAb (Figure 3D). This implies that OX2 is other known protein±protein interactions mediated by
migratory cells (van der Merwe and Barclay, 1996; Mae-the only major ligand for OX2R on rat thymocytes and
independently confirms that OX2 mAb recognizes the naka et al., 1999).
interacting face on the OX2 protein (Preston et al., 1997).
A soluble form of the mouse OX2R behaved in a similar rOX2R Is Expressed by Cells of the Myeloid
manner (data not shown), showing that mouse OX2R Lineage and Can Be Phosphorylated
binds rat OX2 consistent with earlier results (Preston et upon Pervanadate Treatment
al., 1997). The rOX2R appears restricted to the myeloid lineage as
shown by OX102 mAb staining. Macrophages isolated
from the peritoneal cavity (Figure 1A), lung, spleen (dataKinetic Analysis of the Rat OX2±OX2R Interaction
Many of the interactions between proteins at the surface not shown), and leukocyte dendritic cells (Figure 5A)
were highly positive. Isolated microglia, the residentof leukocytes are very weak, but they can be quantified
using surface plasmon resonance and recombinantly macrophage of the brain (Figures 5B and 5C), and half
the OX411 (SIRP) myeloid population from peripheralproduced extracellular regions of these proteins (van
der Merwe and Barclay, 1996). The affinity of the rat blood (Figure 5D) were stained, but peripheral blood B
and T cells (Figures 5E and 5F), activated lymphocytes,OX2±OX2R interaction was calculated at 378C by in-
jecting a series of different concentrations of purified and thymocytes (data not shown) were not stained. The
lower level of OX2R expression on microglia is attributedsoluble OX2CD4d314 over OX2RCD4d314-biotin and
a negative control (CD4d314-biotin) immobilized on a to receptor downregulation due to the high level of OX2
expression in the CNS.streptavidin-coated chip in a BIAcore apparatus. The
Macrophage OX2 Receptor
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Figure 4. The Affinity and Kinetics of the Rat
OX2±OX2R Interaction
All experiments were performed at 378C.
(A) The indicated concentrations of
rOX2CD4d314 (rOX2) were injected at 20 ml/
min through flow cells with 1010 RU of
rOX2RCD4d314-biotin (rOX2R) or 1400 RU
of CD4d314-biotin (Control) immobilized.
The amount of rOX2 that bound rOX2R at
each concentration was calculated as the dif-
ference between the response at equilibrium
in the rOX2R and control flow cell and is plot-
ted in (B). A Scatchard transformation of this
binding data is shown inset in (B), and the
linear fit shown corresponds to a KD of about
2 mM. (C) The dissociation constant of the
rat OX2±OX2R interaction was measured
by injecting 5 ml of soluble rOX2CD4d314
(14.5 mM) at 100 ml/min over immobilized
rOX2RCD4d314-biotin at high (1010 RU) and
low (600 RU) levels and also a negative con-
trol CD4d314-biotin (1100 RU), and data
were collected at 10 Hz. The response in the
control flow cell was subtracted from the
rOX2R flow cells. The data were then normal-
ized (100% at the start of the dissociation
phase), and first order exponential decay
curves were fitted to the data that yield koff
values of 0.80 s21.
There are three tyrosine residues in the cytoplasmic Discussion
domain of OX2R, suggesting that this region may be
involved in the recruitment of intracellular proteins in a The most common structural class of leukocyte-
phosphotyrosine-dependent manner. Treatment of rat restricted membrane proteins contains two IgSF do-
RPCs with pervanadate, which inhibits tyrosine phos- mains and represents 15% of all proteins found at the
phatase activity, gave a strong anti-phosphotyrosine leukocyte cell surface; OX2 and its receptor fall into this
band after rOX2R immunoprecipitation from treated but category (Barclay et al., 1997). Sequence comparison
not untreated cell lysates (Figure 5G). This demonstrates of OX2 and its receptor revealed similarities over and
that rOX2R is a substrate for tyrosine kinases present above those between other members of the IgSF, indi-
in macrophages and implies the ability to recruit intra- cating that the proteins have evolved from a relatively
cellular signaling/adaptor molecules in a phosphate- recent common ancestral precursor. This close recep-
dependent manner. tor:ligand evolutionary relationship has been observed
in other IgSF interactions, notably within the CD2 family
subset (Figure 2B) (Davis and van der Merwe, 1996;
Brown et al., 1998), suggesting that receptor:ligand pairsOX102 mAb Exacerbates the Disease Model
may often evolve from a single gene product originallyExperimental Allergic Encephalomyelitis
able to mediate homophilic binding (Williams and Bar-The distribution of OX2 and its receptor point to a role
clay, 1988). The OX2 and OX2R both have characteristicin the tissue-specific regulation of macrophage biology.
and unusual patterns of additional cysteine residues inTo test this possibility in vivo, the effect of the blocking
their V-like domains that distinguish them from the B7mAb, OX102, was tested in a neural inflammation model,
experimental allergic encephalomyelitis (EAE). EAE is and CD2 subsets that they resemble in topology.
One unusual feature of the OX2R is its high contentcharacterized by microglial activation and perivascular
infiltrates of macrophages and CD41 T cells leading to of potential N-linked glycosylation sites, with eight and
ten in the rat and mouse sequences, respectively (nottissue damage that results in paralysis that resolves over
a few days. Importantly, disease induction is dependent including the unmodified site as determined by peptide
sequencing) (Figure 2A). Two potential sites were glyco-on both the presence (Huitinga et al., 1990) and activity
(Martiney et al., 1998) of peripheral macrophages, im- sylated as determined by direct peptide sequencing,
and many are likely to be occupied given the change inplying a central role for macrophages in disease patho-
genesis. EAE was induced in Lewis rats and the OX2± apparent Mr seen on removal of N-linked sugars by
PNGaseF treatment from z90 kDa to z25 kDa, indicat-OX2R interaction prevented by administering the OX102
mAb just prior to disease onset. The treated animals ing a content of around 70% by weight of carbohydrate.
This is very high for N-linked carbohydrates and is moredeveloped more severe EAE compared to controls, al-
though the duration was similar (Figure 6). These data typical of O-linked sugars found in mucins (Gum, 1992).
However, both mutagenesis data (Preston et al., 1997)support a role for the OX2±OX2R interaction in the regu-
lation of macrophage/microglia activity in vivo. and a comparison to similar IgSF interactions (van der
Immunity
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Figure 5. OX2R Is Restricted to the Myeloid Lineage in Rat and Can Be Tyrosine Phosphorylated upon Pervanadate Treatment
(A) Rat dendritic cells were defined as highly granular, OX62 mAb±positive cells in thoracic duct lymph collected from mesenteric lymphadenec-
tomized rats (Pugh et al., 1983) and were stained with OX102 (bold line) and an isotype-matched negative control (OX21).
(B) Adult CNS leukocyte and microglial cell characterization. Gates are as follows: R1, microglia (CD45lo, CD11b/c1); R2, CNS-associated
macrophages/monocytes/granulocytes (CD45hi, CD11b/c1); R3, lymphocytes (CD45hi, CD11b/c2).
(C) R1-gated microglia are stained with biotinylated OX102 (bold line) or an isotype-matched negative control. Around 20% of cells in R2 were
OX2R1, representing CNS vascular associated macrophages and blood granulocytes, and cells in R3, mostly lymphocytes, were not stained
(data not shown).
(D±F) Peripheral blood leukocytes were stained using biotinylated OX102 and isotype-matched anti-rat lineage markers. Half the OX411 (SIRP)
myeloid population that includes monocytes and granulocytes were OX102 positive (D), but B cells (E) and T cells (F) recognized by OX33
(Anti-rat B220) or OX34 (CD2), respectively, were not stained.
(G) Anti-phosphotyrosine (a-PY) Western blot of OX102 mAb immunoprecipitates from rat RPCs that were left unstimulated (2) or were
stimulated for 10 min with 1 mM sodium pervanadate (1). The bands at 50 and 25 kDa, in both lanes, are the OX102 mAb heavy and light
chain (respectively), which were visualized due to the peroxidase-conjugated anti-mouse secondary antibody.
Merwe et al., 1993) suggest that the OX2±OX2R interac- bind CTLA-4 and CD28) (Tivol et al., 1996) and more
recently for the CD48 (binding CD2 and 2B4) proteintion is mediated by protein and not carbohydrate. It is
possible that the carbohydrate is important in pre- (Brown et al., 1998). It is feasible that OX2 or OX2R also
have multiple ligands, although an interaction that couldventing unwanted cis-interactions and maintaining the
orientation of the OX2R with respect to the membrane. not be fully blocked by either OX102 or OX2 mAbs has
not been detected (data not shown).Several 2-IgSF domain containing CAMs expressed
by leukocytes are able to specifically interact with more The cytoplasmic region of the OX2R contained a NPXY
motif. These motifs are known to interact with the PTB/than one receptor. This has been demonstrated in hu-
man and rodent models for both CD80 and CD86 (both PID binding domains (Kavanaugh et al., 1995) present
Macrophage OX2 Receptor
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Figure 6. Administration of OX102 mAb Exacerbates a Macro-
phage-Dependent Neural Inflammation Disease Model
Figure 7. Scale Diagrammatic Representation of Some of the Possi-
Lewis rats (five per group) were immunized with guinea pig myelin ble Interactions between Macrophages and Nonlymphoid Cells
basic protein to induce EAE as described (MacPhee et al., 1989), and
The dimensions of the proteins are based on known structures as2 mg of purified mAbs OX102 (open circle), OX21 isotype-matched
described for T cell interactions (Barclay et al., 1997). The distalcontrol (open square), or PBS (closed triangle) were administered
N-terminal Ig-like domain of SIRP contains the binding site for theper animal just prior to disease onset. Clinical disease scores are
single Ig-like domain of CD47 (Vernon-Wilson et al., 2000) and isthe calculated means from each group. The experiment is represen-
thus predicted to have the shown topology. The topology of thetative of two separate experiments with comparable outcomes.
CD55/CD97 interaction is not known, although a construct con-
taining three EGF domains of CD97 gave the strongest binding to
CD55, indicating that the two proteins may overlap rather than inter-
in several signaling adaptor molecules. These adaptor act end on (Hamann et al., 1998). The integrin Mac-1 (CD11b/CD18)
molecules are recruited to the cell membrane during interacts with the third domain of CD54 (Diamond et al., 1991).
signaling processes and therefore offer a potential bio-
chemical mechanism to initiate signal transduction as expression influence the development of macrophages
a consequence of OX2R ligation. Several PTB/PID do- in the CNS leading to the microglial phenotype. The
mains have been structurally characterized, and binding phenotype of OX2-deficient mice is consistent with this
is not always dependent on the tyrosine being phos- interpretation (R. M. Hoek et al., submitted), and it is
phorylated within the motif (Howell et al., 1999). NPXY likely that OX2R signaling has similar effects on myeloid
motifs are found in the cytoplasmic regions of b inte- function in other OX2-positive tissues.
grins, and their mutation leads to defects in cell migra- While many soluble factors have been shown to mod-
tion and spreading (Patil et al., 1999). ify macrophage activity, only few membrane proteins
The functional consequence of a cell surface interac- have been shown to do so. The regulation of macro-
tion can be suggested by identifying the cells and tis- phage activity by direct cell±cell contact would allow a
sues that are able to interact. OX2 is expressed on the more localized control than that mediated by cytokines.
cell surfaces of a diverse range of tissues that arguably The only other known myeloid cell surface proteins that
will not share the need for a recently evolved signal have characterized membrane ligands that are broadly
delivered through the OX2 protein. This is supported by distributed are Mac-1 (CD11b/CD18), CD97, and SIRP.
the fact that the OX2 cytoplasmic tail is short (19 amino The SIRP myeloid marker (Adams et al., 1998) interacts
acids) and contains no known signaling motifs. In con- with CD47 (Jiang et al., 1999; Seiffert et al., 1999; Vernon-
trast, a more restricted and functionally related cell type Wilson et al., 2000), CD97 with CD55 (DAF) (Hamann et
expresses the OX2R, which contains a substantial cyto- al., 1996), and Mac-1 with CD54 (Diamond et al., 1991).
plasmic region that has been shown to support tyrosine These interactions are depicted as they might occur at
phosphorylation and is presumably able to initiate an the surface of cells in Figure 7. Interestingly, in common
intracellular signal. This would imply that the role of OX2 with the CD2 subfamily, it is the OX2 V-like domain that
is to ªmarkº certain tissues that have a common need binds the receptor (Preston et al., 1997), suggesting the
to deliver a regulatory signal to myeloid cells expressing complex is arranged with four tandem Ig-like domains
OX2R. The increase in severity of a macrophage-depen- spanning a distance similar to that measured for the
dent inflammatory disease after blockade of the OX2± TCR/MHC and CD2/CD48 complexesÐaround 15 nm.
OX2R interaction implies that OX2R ligation might de- Both the molecular topography of these complexes
liver a restrictive signal to macrophages and thus limit (Wild et al., 1999), and their organization within the zone
macrophage activation and subsequent tissue damage of cell:cell contactÐªthe immunological synapseº (Gra-
in inflamed sites. It is well known that macrophages koui et al., 1999; Monks et al., 1998)Ðhas been shown
isolated from different tissues exhibit a range of different to be important for antigen-specific T cell activation.
morphologies and functional phenotypes, and these dif- The finding of further interactions, such as the OX2±
ferences are attributed to the localized tissue microenvi- OX2R and SIRP±CD47, with this spatial organization
ronment in which the macrophage resides (Gordon, suggests that this distance is important for intracellular
1995; Naito et al., 1996). These include the resident brain communication in a wider context than just antigen-
macrophages or microglia that have both a distinctive specific T cell activation. It is therefore likely that the
ramified morphology and exhibit a general ªdownregula- formation of similar zones of contact or a ªmacrophage
tionº of typical macrophage functions (Perry and Gor- synapseº may well be critical in the tissue-specific con-
trol of macrophage functions.don, 1991). It is possible that the high levels of OX2
Immunity
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Experimental Procedures [pH 7.4], 150 mM NaCl, 3.4 mM EDTA, and 0.005% surfactant P20)
(BIAcore AB) at 378C. Approximately 4000 RU of streptavidin (Pierce
Chemical Co, Rockford, IL) dissolved in 10 mM sodium acetate (pHMonoclonal Antibodies
The monoclonal antibodies used were: OX1 (anti-rat CD45), OX2 5.5) was coupled using amine coupling to a CM5 research grade
chip (BIAcore AB) at 0.2 mg/ml. Biotinylated rOX2RCD4d314 protein(anti-rat OX2), OX21 (anti-human C3bi), OX33 (anti-rat CD45ABC),
OX34 (anti-rat CD2), OX41 (anti-rat SIRP), OX42 (anti-rat CD11b/c), and CD4d314 (control) were immobilized at indicated levels in indi-
vidual flow cells. KD values were obtained both by nonlinear curveOX45 (anti-rat CD48), OX62 (anti-rat dendritic cells), OX68 (anti-rat
CD4d314), W6/32 (anti-human HLA). All mAbs are referenced by fitting of the Langmuir binding isotherm and Scatchard transforma-
tions of the binding data. koff values were determined by fitting a firstthe European Collection of Animal Cell Cultures (ECACC; Porton
Down, Salisbury, UK). order exponential decay curve to normalized data (Origin, MicroCal
software, version 5.0) obtained from individual flow cells containing
rOX2RCD4d314 after the subtraction of the negative controlProduction of OX102 mAb
(CD4d314). kon values were obtained by using this koff value in BIA-Male BALB/c mice at 6 weeks of age were immunized six times
evaluation 3.0 software over the association binding phase.with either 0.1±0.25 mg of a crude Tween-40 membrane fraction
solubilized from rat (PVG) thioglycollate-elicited peritoneal cells or
unlysed whole cells. A mouse producing a good immune response Purification of rOX2CD4d314
to resident rat peritoneal cells (RPCs) was boosted by an intrasplenic Rat OX2CD4d314 soluble chimeric protein was purified by immu-
injection of 4 3 106 unlysed RPCs. The spleen was removed 4 days noaffinity chromatography using a OX68-Sepharose 4B column from
later and fused to NS-1 myeloma cells to produce hybridomas using the supernatant of a stably transfected CHO.K1 cell line (Preston
standard techniques. Hybridoma supernatants were screened for et al., 1997). Purified protein was then fractionated by gel filtration
their ability to bind the rat RPC cell surface by flow cytometry and on a Superdex S-200 column (Pharmacia, Uppsala, Sweden) prior
then for their ability to block the binding of rOX2CD4d314-coated to BIAcore analysis to exclude protein aggregates that are known
beads. One antibody was obtained; the hybridoma was recloned to influence binding measurements (van der Merwe and Barclay,
three times and named OX102. 1996). The extinction coefficient was determined by amino acid
analysis to be 44,440 M21cm21. At least 90% of the rOX2CD4d314
protein could be immunoprecipitated using the OX2 mAb (data notPurification of the rOX2R
The OX102 antigen was purified by affinity chromatography from shown), indicating that the bulk of the preparation was correctly
folded and antigenically active.rat splenic extracts as in Sunderland et al. (1979) except the antigen
was not eluted by the normal high pH but required 0.5% SDS at
558C. Amino-terminal sequencing was performed using an auto- Deglycosylation of rOX2R
mated Edman degradation in an Applied Biosystems Procise 494A Approximately 0.5 mg of purified rOX2R was incubated without or
protein sequencer (Perkin-Elmer Ltd, UK). with 10 U of PNGaseF (NEB, Beverly, MA), and aliquots (3 ng) were
removed at the indicated times. The aliquots were run under nonre-
Cloning and Expression of rOX2R ducing conditions on a 10% SDS polyacrylamide gel, and proteins
The cDNA for the OX102 antigen was cloned by a modification of were blotted onto Hybond C-extra nitrocellulose (Amersham Inter-
the SMART system (Clontech, Palo Alto, CA) using cDNA primed national plc., Bucks, UK) overnight at 30V and probed with mAbs
and tagged at the 39 end with gactcgagttgacatcgagg(t)20v and at OX102 or OX21 (negative control) for 1 hr at room temperature. A
the 59 end using aagcagtggtaacaacgcagagtacgcggg in a standard peroxidase-conjugated rabbit anti-mouse secondary serum (DAKO
cDNA synthesis using Superscript II (GIBCO-BRL, UK) reverse tran- Immunoglobulins, Denmark) was used at 1:2000, developed using
scriptase and poly(A)1 RNA from rat (PVG) RPCs. The 59 end of the ECL1 luminescence detection system (Amersham), and detected
rOX2R cDNA was amplified in a 59 RACE RT-PCR using 59 chemically using Kodak LS scientific imaging film (Kodak, UK).
phosphorylated oligonucleotides to the 59 tag (aagcagtggtaacaacg
cagagt) and an antisense degenerate oligonucleotide (tgcatngtytgrt
Pervanadate Activation of Cells
tyttrtc) corresponding to amino acids DK(N)QTMQ. PCR products
We harvested 9 3 107 rat RPCs by peritoneal lavage in PBS, which
at a low annealing temperature (44 6 28C) were blunt-end cloned
were subdivided into two aliquots, and either stimulated at 378C for
into SmaI-digested and phosphatase-treated PCRScript vector
10 min with 1 mM sodium pervanadate or left unstimulated before
(Stratagene, La Jolla, CA). Sequencing of inserts revealed several
lysis in ice-cold WOP-40 buffer (1% NP-40, 50 mM Tris-HCl [pH
clones containing the N-terminal SCP peptide sequence and an in-
8.0], 150 mM NaCl, 1 mM EDTA, 10 mM NaF, 10 mM sodium pyro-
frame typical leader sequence. The full-length cDNA was cloned by
phosphate supplemented with 0.4 mM sodium vanadate and prote-
a 39 RACE reaction using gactcgagttgacatcgagg (antisense) against
ase inhibitors). For each immunoprecipitation, 2.25 3 107 cell equiva-
the 39 tag and tcatggcggccgctgctcccctac (sense) designed from
lents were rotated with 50 ml 20% slurry of OX102 or a negative
the leader sequence. The oligonucleotides contain NotI and XhoI
control mAb covalently attached to Sepharose overnight at 48C.
sites (in italics) that were used to clone the 39 RACE PCR product
mAb-coupled Sepharose beads were pelleted and washed before
prior to sequencing. The full-length mouse OX2R was cloned by
boiling in 20 ml 23 SDS-PAGE sample buffer, resolved by SDS-
nested 39 RACE PCR as above but using sense oligonucleotide
PAGE, blotted, and probed using anti-phosphotyrosine mAb PY-20
gagtgagcggcggaaaaccagaaaaccgaaatg initially and then gagcggc
(TCS, Bucks, UK).
gggcggccgcaaaaccgaaatgttttgct and BALB/c mouse RPC poly(A)1
mRNA as a template. The full-length rOX2R cDNA was blunt-end
Microglia Isolationligated into the eukaryotic expression vector pEF-BOS and trans-
Nonperfused whole rat CNS (brain and spinal cord) from 8-week-fected by the calcium phosphate method into HEK293T cells. Both
old rats was digested with collagenase/Dnase, and cells were iso-rat and mouse soluble OX2R proteins were produced by amplifying
lated over Percoll and subsequently stained and gated as describedthe extracellular regions of OX2R by PCR using oligonucleotides
(Sedgwick et al., 1991).(sense) ccctacctgtctagagaaagagcaccgagtgag and (antisense) cctaa
taatgtcgacccccctctacccagttc. Products were ligated in frame using
XbaI/SalI digestion to rat CD4d314 (constructs contained the se- Cell Staining Assays
quence LGRGGSTSIT) and a BirA biotinylation sequence at the C Generation of the multivalent OX2 and CD2 binding reagents using
terminus of the protein (in vector pEF-BOS-XB). The proteins were either biotinylated or avidin-coated fluorescent beads (Spherotech
expressed in HEK293T cells, enzymatically biotinylated, and used Inc. Libertyville, IL) have been described previously (Preston et al.,
as described (Brown et al., 1998). 1997; Brown et al., 1998). Dual labeling was performed as described
previously using standard techniques using a streptavidin quantum
red conjugate (Sigma, Dorset, UK) to detect biotinylated OX102 andAffinity and Kinetic Analysis of the OX2±OX2R Interaction
Affinity and kinetic analysis was performed on a BIAcore 2000 (BIA- a FITC-conjugated goat anti-mouse adsorbed against rat immuno-
globulins (Serotec Ltd., Oxon).core AB, St. Albans, UK) using running buffer HBS (10 mM HEPES
Macrophage OX2 Receptor
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EAE Experiments B.J., Martin, M.E., Efstathiou, S., Craxton, M., and Macaulay, H.A.
(1995). The DNA sequence of human herpesvirus-6: structure, cod-Animals were housed according to institutional and Home Office
regulations in the Sir William Dunn School of Pathology animal facil- ing content, and genome evolution. Virology 209, 29±51.
ity. Lewis rats (five per group) were immunized with guinea pig Gorczynski, R.M., Chen, Z., Fu, X.M., and Zeng, H. (1998). Increased
myelin basic protein (MBP) to induce EAE (MacPhee et al., 1989) expression of the novel molecule OX-2 is involved in prolongation
and injected i.v. 9 days after MBP immunization (just prior to disease of murine renal allograft survival. Transplantation 65, 1106±1114.
onset) with either 2 mg of purified mAbs in PBS or PBS alone.
Gorczynski, L., Chen, Z., Hu, J., Kai, Y., Lei, J., Ramakrishna, V.,
Disease was scored as in MacPhee et al. (1989).
and Gorczynski, R.M. (1999a). Evidence that an OX-2-positive cell
can inhibit the stimulation of type 1 cytokine production by bone
Acknowledgments marrow-derived B7-1 (and B7-2)-positive dendritic cells. J. Immunol.
162, 774±781.
We are grateful to Steve Simmonds for the experiments on EAE,
Gorczynski, R.M., Cattral, M.S., Chen, Z., Hu, J., Lei, J., Min, W.P.,Diana Zalenika for advice on RACE procedures, Anton van der
Yu, G., and Ni, J. (1999b). An immunoadhesin incorporating theMerwe for BIAcore analysis, and Gordon MacPherson for providing
molecule OX-2 is a potent immunosuppressant that prolongs allo-rat dendritic cells. The MRC and EU biotechnology program sup-
and xenograft survival. J. Immunol. 163, 1654±1660.ported this work, and the DNAX Research Institute is supported by
Gorczynski, R.M., Cohen, Z., Fu, X.M., and Lei, J. (1999c). Anti-ratthe Schering Plough Corporation.
OX-2 blocks increased small intestinal transplant survival after por-
tal vein immunization. Transplant Proc. 31, 577±578.Received May 24, 2000; revised June 27, 2000.
Gordon, S. (1995). The macrophage. Bioessays 17, 977±986.
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